Here’s a personal, non-exhaustive selection of highly awaited phase 3 trials that may shape practice within the next year – Paolo Tarantino

Good clinical practice does not mean endless and mindless tasks that no one knows why they exist aside from generating work and money for CROs – Amer Zeidan

A new cornerstone paper by EORTC, EORTC Breast Cancer Group and Imaging groups – Icro Meattini

ASCO and AACR really show their commitment to mentoring new clinical investigators in the science – John Byrd

Together, we can make a difference! – Vivek Subbiah

All my appreciation for Naveen Pemmaraju for being a world leader in the field of BPDCN (yes 123 field !) and MPN – Nitin Jain

St. Baldrick’s is proud to announce 34 new grants to childhood cancer researchers at 23 institutions totaling $8.4 million – St. Baldrick’s Foundation

This team tirelessly synthesized and tested over 10,000 derivatives, eventually identifying a compound with exceptional anti-cancer activity and no toxicity – Sendurai Mani

So great to spend the day with visionary NCI DIrector Monica Bertagnolli and so many leaders in clinical research – Neal Meropol

ASCO expert panel chaired by Navneet Singh and Megan Daly has published an update on management of stage III NSCLC based on the ADAURA and KEYNOTE-671 trials – Navneet Singh